- Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations
-
Danpanichkul P, Suparan K, Prasitsumrit V, Ahmed A, Wijarnpreecha K, Kim D
- KMID: 2563408
- Clin Mol Hepatol.
- 2025 Jan;31(1):74-89.
- doi: 10.3350/cmh.2024.0631
One-third of adults across the globe exhibit metabolic dysfunction-associated steatotic liver disease (MASLD)―formerly known as nonalcoholic fatty liver disease (NAFLD). To date, MASLD is the fastest-growing etiology of chronic liver... -
- CITED
-
- Close
- SHARE
-
- Close
